Letter

Making decisions about hormone replacement therapy: Preparations containing oestrogen should not be given during treatment for breast cancer

BMJ 2003; 326 doi: 10.1136/bmj.326.7403.1398 (Published 19 June 2003)
Cite this as: BMJ 2003;326:1398.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Christopher P Hinton, consultant surgeon (christopherhinton@tiscali.co.uk),
  2. Claire Coventry, clinical assistant,
  3. Bridget Borrowclough, clinical assistant
  1. Princess Royal Hospital NHS Trust, Telford, Shropshire TF1 6TF

    EDITOR—We read with interest the clinical review by Rymer et al on making decisions about hormone replacement.1 The article provides a useful and informed guide to the indications for hormone replacement and a helpful analysis …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular